The MicrocynVS® family of animal healthcare products are the ONLY animal healthcare products with the original Microcyn® Technology formulated exclusively for North American veterinarians. With over ten million creatures successfully treated with Microcyn® Technology—both four-legged and two—there has never been a single report of a serious adverse effect. It is a superior hypochlorous acid solution that is clinically proven safe, non-toxic and effective. Can safely be used around the nose, eyes, ears and mouth and requires no mixing or dilution.
About Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals is a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including dermatological conditions, wound care, animal health care, eye care, nasal care and oral care. In 2004, Sonoma launched Microcyn® Technology, the first revolutionary stable patented HOCl formulation in a bottle. The company’s Microcyn-based products, which are sold throughout the United States and internationally, have improved outcomes for more than ten million patients globally by reducing infections, itch, pain, scarring and harmful inflammatory responses. The company’s headquarters are in Boulder, Colorado, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands.